Accessibility Menu
Respiri logo

Respiri(ASX) RSH

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-98%
5 Year-86%
1 Year-54%
1 Month+8%
N/A
Respiri last closing stock price
MetricPriceDate
Last closeAUD 0.012026-08-14
Respiri stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+30%AUD 0.012026-08-06
1 month+8.33%AUD 0.012026-07-15
3 month+18.18%AUD 0.012026-05-15
Year to date-45.83%AUD 0.022025-12-31
1 year-53.57%AUD 0.032025-08-14
3 year-60.61%AUD 0.032023-08-15
5 year-85.87%AUD 0.092021-08-13
Since inception-98.4%AUD 0.752006-11-15

Respiri Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$2.06M

Net Income (TTM)

-A$13.97M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Feb 26, 2025

RSH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Respiri

Respiri Limited is an innovative e-health software-as-a-service (SaaS) provider based in Melbourne, Australia. The company focuses on the research, development, and commercialization of medical devices, particularly in mobile health applications.

Products and Services
  • Wheezo: A device for identifying wheezing in children
  • Respiri mobile application for health monitoring
  • Respiri health portal for patient data management
Growth Outlook
  • Recent revenue of AUD 1.54 million indicates strong market interest
  • Focus on expanding product offerings in the healthcare sector
  • Potential for increased adoption of digital health solutions
Financial Highlights
  • Quarterly revenue increased significantly from AUD 309,466 to AUD 1.54 million
  • Gross profit margin improved to 80.34% in the latest quarter
  • Cash reserves reached AUD 1.25 million, providing operational stability
Respiri Limited is positioned in the healthcare sector, specifically within medical devices, and is dedicated to enhancing patient care through technology. The company's flagship product, Wheezo, addresses a critical need in pediatric healthcare by enabling parents and caregivers to monitor wheezing in children effectively. The recent financial performance shows a notable increase in revenue, reflecting growing demand for its innovative solutions. With a focus on expanding its product line and leveraging the increasing trend towards digital health, Respiri Limited presents an intriguing opportunity for investors interested in the evolving healthcare landscape. The company's financial stability, as indicated by its cash reserves, supports its ongoing development and market expansion efforts.
AI Generated • Jul 18, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Marjan Mikel

Website

www.respiri.co

Headquarters

Melbourne, VIC 3004, AU

RSH Financials

Key Financial Metrics (TTM)

Gross Margin

99.16%

Operating Margin

-1673.36%

Net Income Margin

-1560.30%

Return on Equity

-411.64%

Return on Capital

-194.56%

Return on Assets

-115.16%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-A$1.66M

Operating Income

-A$14.47M

EBITDA

-A$14.35M

Operating Cash Flow

-A$12.81M

Capital Expenditure

-A$9.16K

Free Cash Flow

-A$12.82M

Cash & ST Invst.

A$1.25M

Total Debt

A$87.37K

Respiri Performance Analysis

Respiri annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 253,688N/A
20232023-06-30AUD 70,533-72.2%
20242024-06-30AUD 453,264542.6%
20252025-06-30AUD 3,085,051580.6%
Respiri sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-06-30516.6%
Q22023-12-31143.0%
Q42024-06-30109.9%
Q22024-12-31399.0%
Respiri annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.01N/A
20232023-06-30AUD -0.01-20.9%
20242024-06-30AUD -0.01-2.8%
20252025-06-30AUD -0.012.9%
Respiri sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-06-30-18.2%
Q22023-12-3110.3%
Q42024-06-30N/A
Q22024-12-3114.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

A$1.54M

+15588.8%

Gross Profit

A$1.24M

+204.1%

Gross Margin

80.34%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

2

N/A

Net Income

-A$3.64M

-41.2%

EBITDA

-A$3.61M

-16.9%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

A$1.25M

+443.5%

Total Debt

A$87.37K

N/A

Accounts Receivable

A$371.40K

+239.1%

Inventory

A$2.92M

+10.5%

Long Term Debt

A$26.51K

N/A

Short Term Debt

A$60.86K

N/A

Return on Assets

-1.15%

N/A

Return on Invested Capital

-2.77%

N/A

Free Cash Flow

-A$4.16M

-67.1%

Operating Cash Flow

-A$4.16M

-67.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AMT.AXAllegra Medical Technologies Limited
A$0.03+0.00%
VTI.AXVisioneering Technologies, Inc.
A$0.07+0.00%
UCM.AXUscom Limited
A$0.01+9.09%
UBI.AXUniversal Biosensors, Inc.
A$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About RSH

What is the current price of Respiri?

Respiri is trading at N/A per share.

What is the 52-week range for Respiri?

Over the past 52 weeks, Respiri has traded between N/A and N/A.

How much debt does Respiri have?

As of the most recent reporting period, Respiri reported total debt of A$57.42K.

How much cash does Respiri have on hand?

Respiri reported A$394.24K in cash and cash equivalents in its most recent financial results.

What is Respiri’s dividend yield?

Respiri does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services